FFA
PRAX icon

Farther Finance Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Farther Finance Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$73.4K Buy
252
+15
+6% +$4.96K ﹤0.01% 3111
2026
Q2 		$79.4K Sell
237
-1
-0.4% -$317 ﹤0.01% 2895
2026
Q1 		$76K Sell
238
-130
-35% -$40.2K ﹤0.01% 2711
2025
Q4 		$108K Buy
368
+138
+60% +$25.7K ﹤0.01% 2301
2025
Q3 		$12.2K Hold
230
– – ﹤0.01% 3350
2025
Q2 		$9.67K Buy
230
+30
+15% +$1.14K ﹤0.01% 3098
2025
Q1 		$7.17K Buy
+200
New +$12.5K ﹤0.01% 2896
2024
Q1 		– Sell
-1,000
Closed -$22.3K – 3705
2023
Q4 		$22.3K Hold
1,000
– – ﹤0.01% 1304
2023
Q3 		$25.6K Buy
+1,000
New +$18.9K ﹤0.01% 1011

Other funds holding PRAX

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Farther Finance Advisors's PRAX Position: Q3 2026 in Review

Farther Finance Advisors increased its Praxis Precision Medicines (PRAX) stake by 6.3% in Q3 2026, buying an estimated $4.96K and bringing the position to 252 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3111.

Farther Finance Advisors first reported a position in PRAX in Q3 2023 and has held it in 9 quarters since. The position peaked at $108K in Q4 2025. 4 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • Farther Finance Advisors held 252 shares of Praxis Precision Medicines worth $73.4K as of Q3 2026.
  • Farther Finance Advisors bought 15 Praxis Precision Medicines shares in Q3 2026, an estimated $4.96K.
  • Praxis Precision Medicines made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3111 holding.
  • Farther Finance Advisors first reported a position in Praxis Precision Medicines in Q3 2023 and has held it in 9 quarters since.
  • Farther Finance Advisors's Praxis Precision Medicines position peaked at $108K in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.